Tag: Zelira Therapeutics
Zelira Therapeutics: Raises $1.77m through US-based investors
Zelira Therapeutics Raises $1.77m through US-based investorsZelira Therapeutics (ZLD) raises $1.77 million to progress its clinical trials
The...
Zelira Therapeutics: Launches first product line, RAF FIVE
Zelira Therapeutics: Launches first product line, RAF FIVEZelira Therapeutics (ZLD) launches its first product line, RAF FIVE, through...
Zelira Therapeutics: Launches Zenivol in Australia
Zelira Therapeutics (ZLD) has launched its proprietary cannabinoid medicine, Zenivol, in Australia
The company has received approval from...
Zelira Therapeutics: Confirms ZTL-103 is safe and well-tolerated
Zelira Therapeutics: Confirms ZTL-103 is safe and well-toleratedZelira Therapeutics has confirmed its phase one dose-escalation trial of ZTL-103...